Farmacias Benavides, S.A.B. de C.V.
FBNVF
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -24.18% | -24.66% | 3,064.05% | -16.84% | 494.66% |
| Total Depreciation and Amortization | 17.52% | 7.51% | -34.25% | 53.86% | 39.82% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 184.13% | -34.41% | -293.96% | 0.43% | -32.87% |
| Change in Net Operating Assets | 19.77% | 35.76% | 33.57% | 136.59% | -261.16% |
| Cash from Operations | 97.98% | 19.76% | -88.86% | 101.69% | -52.65% |
| Capital Expenditure | 88.42% | -- | 37.64% | 40.55% | -156.05% |
| Sale of Property, Plant, and Equipment | -70.10% | -- | -47.62% | -47.70% | 287.32% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -90.67% | 192.36% | -175.28% | 131.79% | 375.66% |
| Cash from Investing | 89.66% | -2,877.87% | -5.56% | 44.64% | -109.43% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -110.07% | 22.03% | 398.28% | 3.06% | 7.72% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -76.57% | -13.73% | 35.81% | -1.78% | -70.25% |
| Cash from Financing | -105.94% | 6.64% | 224.83% | -16.23% | -20.08% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 30.30% | 2.32% | 14.95% | 154.63% | -184.14% |
